Venom Trilogy: How Tom Hardy's Antihero Captured Box Office Success

The most recent film in the Venom saga continues to draw crowds, achieving remarkable success at the box office. Although the movies have not been critically acclaimed, as seen in their Rotten Tomatoes ratings, Tom Hardy's rendition of the renowned antihero remains a powerful draw for audiences. With the trilogy now culminating, it has met financial expectations with a strong showing.

"Venom: The Last Dance," which was produced on a budget of $120 million, has soared past $300 million in global ticket sales over the weekend alone. While movie studios typically aim for profits well above production costs to cover marketing and other expenses—often twice the budget—the film's performance is nonetheless impressive. Venom continues to be a standout in Sony's depiction of the Spider-Verse.

The success of this installment raises the question of what's next for the Venom franchise. Although Tom Hardy's current story arc has wrapped up, this could potentially set the stage for new adventures, perhaps introducing the character Knull. The stage seems set for a new symbiote to step forward and extend the Venom legacy.